All Pharma News
ObsEva Announces Delisting from SIX Swiss Exchange & Exemption

ObsEva Announces Delisting from SIX Swiss Exchange & Exemption
GLOBENEWSWIRE
03 Apr 2024
Share Share
ObsEva Announces Update on Board of Directors

ObsEva Announces Update on Board of Directors
GLOBENEWSWIRE
19 Mar 2024
Share Share
ObsEva winds down and lays off staff as money, options run out

ObsEva winds down and lays off staff as money, options run out
FIERCE BIOTECH
28 Feb 2024
Share Share
ObsEva Announces Wind-Down of Operations

ObsEva Announces Wind-Down of Operations
GLOBENEWSWIRE
27 Feb 2024
Share Share
Geneva Court Grants Temporary Moratorium to ObsEva

Geneva Court Grants Temporary Moratorium to ObsEva
GLOBENEWSWIRE
31 Jan 2024
Share Share
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals

ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
GLOBENEWSWIRE
30 Nov 2023
Share Share
ObsEva Files half Year 2023 Financial Statements

ObsEva Files half Year 2023 Financial Statements
GLOBENEWSWIRE
27 Sep 2023
Share Share
ObsEva gets China rights to pregnancy drug over missed deadline

ObsEva gets China rights to pregnancy drug over missed deadline
James Waldron FIERCE BIOTECH
13 Jul 2023
Share Share
ObsEva Recovers Full Worldwide Rights on Nolasiban

ObsEva Recovers Full Worldwide Rights on Nolasiban
GLOBENEWSWIRE
13 Jul 2023
Share Share
ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023
GLOBENEWSWIRE
30 Jun 2023
Share Share